Yunxi Road 147#,Jiaojiang,Taizhou,Zhejiang,China | 
(86)0576-85588191
Appreciation party
2017-06-09
Three major changes combed! Supply chain reform in the whole industry chain of drug research and development, production and purchase"
- Categories:Company news
- Time of issue:2017-06-09 15:16
- Views:
(Summary description)This year, "double 11", CFDA issued the "8 companies on 11 applications for drug registration approval" (2015 229th), so that the entire pharmaceutical industry shocked. However, the day before the double 11, the highest national leaders for the first time put forward "supply side structural reforms", half a month so far has frequently stressed that "supply side reforms" have recently become one of the hot areas of economic Chinese words.
For the pharmaceutical industry, the rationale for this year, CFDA and other ministries promulgated a series of announcements and policies, you can find that the pharmaceutical industry is from research and development, production and procurement of 3 aspects of the "supply side" reform". It can be foreseen that the supply side reform of the pharmaceutical industry in the future will only strengthen, and there is no possibility of backing off.
Three major changes combed! Supply chain reform in the whole industry chain of drug research and development, production and purchase"
(Summary description)This year, "double 11", CFDA issued the "8 companies on 11 applications for drug registration approval" (2015 229th), so that the entire pharmaceutical industry shocked. However, the day before the double 11, the highest national leaders for the first time put forward "supply side structural reforms", half a month so far has frequently stressed that "supply side reforms" have recently become one of the hot areas of economic Chinese words.
For the pharmaceutical industry, the rationale for this year, CFDA and other ministries promulgated a series of announcements and policies, you can find that the pharmaceutical industry is from research and development, production and procurement of 3 aspects of the "supply side" reform". It can be foreseen that the supply side reform of the pharmaceutical industry in the future will only strengthen, and there is no possibility of backing off.
- Categories:Company news
- Time of issue:2017-06-09 15:16
- Views:
Information
This year, "double 11", CFDA issued the "8 companies on 11 applications for drug registration approval" (2015 229th), so that the entire pharmaceutical industry shocked. However, the day before the double 11, the highest national leaders for the first time put forward "supply side structural reforms", half a month so far has frequently stressed that "supply side reforms" have recently become one of the hot areas of economic Chinese words.
For the pharmaceutical industry, the rationale for this year, CFDA and other ministries promulgated a series of announcements and policies, you can find that the pharmaceutical industry is from research and development, production and procurement of 3 aspects of the "supply side" reform". It can be foreseen that the supply side reform of the pharmaceutical industry in the future will only strengthen, and there is no possibility of backing off.
Keyword:
Scan the QR code to read on your phone
Next:
None
Next:
None
Relevant news
Recreational activities
2017-06-09
Copyright ©Zhejiang Haizhou Pharmaceutical Co., Ltd. 浙ICP备12026669号 Powered by 300.cn
